Behzad Aghazadeh, 10% Owner at Mirati Therapeutics, Inc. (MRTX), sold 247,562 shares at $73.43 ($18.1M) on 2019-03-19, disclosed to the SEC on 2019-03-20.
Open-market sale of $18.1M MRTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.43 | 100,000 | $7.3M | 40.5% |
| 2 | $73.43 | 100,000 | $7.3M | 40.5% |
| 3 | $72.80 | 23,781 | $1.7M | 9.5% |
| 4 | $72.80 | 23,781 | $1.7M | 9.5% |
| Total | $73.31 avg | 247,562 | $18.1M | 100% |
| Filing → |
| IMMU | BUY | 2019-12-09 | $35.0M | — | Filing → |
| MRTX | SELL | 2019-07-25 | $6.4M | — | Filing → |
| MRTX | SELL | 2019-02-21 | $50.1M | — | Filing → |